Insulet (NASDAQ:PODD): Q2 GAAP EPS of $0.22 beats by $0.22. Revenue of $226.3M (+27.8% Y/Y) beats by $13.89M. Press Release
seekingalpha · 1天前
Insulet (PODD) Surpasses Q2 Earnings and Revenue Estimates
finviz · 1天前
Insulet Reports Second Quarter 2020 Revenue Increase of 28% Year-Over-Year
finviz · 1天前
Earnings Preview: Insulet (PODD) Q2 Earnings Expected to Decline
Insulet (PODD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/30 16:34
Wells Fargo Initiates Coverage On Insulet with Overweight Rating, Announces Price Target of $231
Wells Fargo analyst Lawrence Biegelsen initiates coverage on Insulet (NASDAQ:PODD) with a Overweight rating and announces Price Target of $231.
Benzinga · 07/28 10:24
Abbott Deal, UnitedHealth Coverage Push Up Tandem Shares
GuruFocus.com · 07/06 21:03
Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020